" The restructured vaccine, developed by the Academy of Military Medical Sciences (AMMC), is based on the 2014 mutant gene type and especially targets the strain plaguing west Africa, Xinhua reported."
Beijing, Dec 18 - An Ebola vaccine developed by a military-tied research institute has been approved to enter the human test stage, the Chinese People's Liberation Army's (PLA) General Logistics Department announced Thursday.

The restructured vaccine, developed by the Academy of Military Medical Sciences (AMMC), is based on the 2014 mutant gene type and especially targets the strain plaguing west Africa, Xinhua reported.

The vaccine is currently in the form of a freeze-dried powder, which will keep it stable for at least two weeks in temperatures of up to 37 degrees Celsius. This will make it suitable for the tropical west African region and assist with large-scale production, according to a review report by 17 experts in the field.


comments powered by Disqus
Read more on:
 
PERMALINK

http://www.nerve.in/news:2535002429293
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.

STORY OPTIONS
  Email this story to a friend
  XML feed for Asia
 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.